REFERENCES:
  1. Saleem S. Aslam HM, Anwar M, et al. Fahr’s syndrome: literature review of current evidence. Orphanet J Rare Dis. 2013;8:156. Published 2013 Oct 8. doi:10.1186/1750-1172-8-156 https://pubmed.ncbi.nlm.nih.gov/24098952/
  2. Sapkota D, Neupane S, Pant P, Shrestha O, Singh P, Sapkota D. Fahr’s disease presenting as Parkinson’s disease along with dysphagia and dysarthria: A case report. Clin Case Rep. 2023;11(5):e7358. Published 2023 May 20. doi:10.1002/ccr3.7358 https://pubmed.ncbi.nlm.nih.gov/37220519/
  3. Shoib, S., Maqbool Dar, M., Arif, T., Bashir, H., & Ahmed, J. (2012). Fahr’s Disease Presenting as Mania: A Case Report. Iranian journal of psychiatry and behavioral sciences, 6(2), 102-104. PMCID: PMC3940010 | PMID: 24644491. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940010/
  4. Waleed Tariq Siddiqui, Gaggan Brar, Bilori Bilori. Fahr’s disease,Postgraduate Medical Journal , Volume 98, Issue 1166, December 2022, Page e39, https://doi.org/10.1136/postgradmedj-2021-140309
  5. Rastogi, R., Singh, A. K., Rastogi, U. C., Mohan, C., & Rastogi, V. (2011). Fahr’s syndrome: a rare clinico-radiologic entity.Medical journal, Armed Forces India, 67 (2), 159-161. https://doi.org/10.1016/S0377-1237(11)60020-8
  6. Modrego PJ, Mojonero J, Serrano M, Fayed N. Fahr’s syndrome presenting with pure and progressive presenile dementina. Neurol Sci.2005;26(5):367-369. doi:10.1007/s10072-005-0493-7 https://pubmed.ncbi.nlm.nih.gov/16388376/
  7. Magalhães M, Alves M, Paulino Ferreira L, Alves J, Durães D. Basal Ganglia Calcification: A Case Report of Two Siblings with Fahr’s Disease. Cureus. 2024;16(2):e53434. Published 2024 Feb 2. doi:10.7759/cureus.53434 PMCID: PMC10838373 | PMID: 38314389
  8. Batla A, Tai XY, Schottlaender L, Erro R, Balint B, Bhatia KP. Deconstructing Fahr’s disease/syndrome of brain calcification in the era of new genes. Parkinsonim Relat Disord. 2017;37:1-10. doi:10.1016/j.parkreldis.2016.12.024 https://pubmed.ncbi.nlm.nih.gov/28162874/
  9. Donzuso G, Mostile G, Nicoletti A, Zappia M. Basal ganglia calcifications (Fahr’s syndrome): related conditions and clinical features [published correction appears in Neurol Sci. 2019 Aug 23;:]. Neurol Sci .2019;40(11):2251-2263. doi:10.1007/s10072-019-03998-x https://pubmed.ncbi.nlm.nih.gov/31267306/
  10. Ramos EM, Oliveira J, Sobrido MJ, et al. Primary Familial Brain Calcification. 2004 Apr 18 [Updated 2017 Aug 24]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. https://www.ncbi.nlm.nih.gov/books/NBK1421/
  11. Liu MJ, Li JW, Shi XY, Hu LY, Zou LP. Epileptic seizure, as the first symptom of hypoparathyroidism in children, does not require antiepileptic drugs. Childs Nerv Syst. 2017;33(2):297-305. doi:10.1007/s00381-016-3264-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352736/
  12. Snijders BM, Mathijssen G, Peters MJ, et al. The effects of etidronate on brain calcifications in Fahr’s disease or syndrome: rationale and design of the randomized, placebo-controlled, double-blind CALCIFADE trial. Orphanet J Rare Dis. 2024;19(1):49. Published 2024 Feb 7. doi:10.1186/s13023-024-03039-7 https://pubmed.ncbi.nlm.nih.gov/38326858/
  13. Oliveira JR, Oliveira MF. Primary brain calcification in patients undergoing treatment with the bisphosphonate alendronate. Sci Rep. 2016;6:22961. Published 2016 Mar 15. doi:10.1038/srep22961 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792151/